Prescription rates for Leucovorin nearly doubled in the weeks following a Sept. 22 federal press conference where Health Secretary Robert F. Kennedy Jr. recommended the drug as a treatment for some children with autism.
A line chart showing a spike in prescription rates for Leucovorin for following a Sept. 22 press conference by the federal government citing the drug as a potential treatment for children with cerebral folate deficiency.